ARCHIVES

IOM Report Links Agent Orange, CLL

This article is from The Cancer Letter archive.

Vol. 29 No. 04 | January 24, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Recieves Two Proposals For Antineoplaston Trials, None For Children; Stubble Elected To NAS

June 19, 1992

RFP Suggestions For Immunodiagnosis Research Offered

October 22, 1976

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

NIH “RFA Game” Defeats Purpose Of OAM, Advisor Says

September 30, 1994

Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting.

April 16, 2004

DCT Board Agrees To Use Of Program Announcement For New Surgery Grants

March 13, 1981